SEC Filing Summary: Oculus Innovative Sciences, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Oculus Innovative Sciences, Inc. on April 24, 2007, reporting events occurring on April 20, 2007. The registrant is a Delaware corporation headquartered in Petaluma, California. Note: The request metadata references "Sonoma Pharmaceuticals, Inc.," but the filing text explicitly identifies the registrant as "Oculus Innovative Sciences, Inc."
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding corporate governance changes and does not contain financial statements.
Material Changes
The material change reported is the appointment of a new independent director. Effective April 20, 2007, Dr. Jay Edward Birnbaum was elected to the Board of Directors and will serve on the Audit Committee.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirm the identity of the registrant as Oculus Innovative Sciences, Inc., distinct from Sonoma Pharmaceuticals, Inc.
- Verify Dr. Jay Edward Birnbaum's qualifications and independence status for the Audit Committee.
- Review subsequent filings for any financial updates, as this 8-K contains no financial data.